Title | Drug Development and Registration |
Abbreviation | Drug Dev. Regist. |
Publication Type | Journal |
Subject Area, Categories, Scope | Pharmaceutical Science (Q3); Drug Discovery (Q4) |
h-index | 5 |
Overall Rank/Ranking | 19643 |
SCImago Journal Rank (SJR) | 0.191 |
Impact Score | 0.74 |
Publisher | Center of Pharmaceutical Analytics |
Country | Russian Federation |
ISSN | 26585049, 23052066 |
Best Quartile | Q3 |
Coverage History | 2020-2022 |
Drug Development and Registration is a journal covering the technologies/fields/categories related to Pharmaceutical Science (Q3); Drug Discovery (Q4). It is published by Center of Pharmaceutical Analytics. The overall rank of Drug Development and Registration is 19643. According to SCImago Journal Rank (SJR), this journal is ranked 0.191. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 5. The best quartile for this journal is Q3.
The ISSN of Drug Development and Registration journal is 26585049, 23052066. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Drug Development and Registration is cited by a total of 157 articles during the last 3 years (Preceding 2022).
The Impact IF 2022 of Drug Development and Registration is 0.74, which is computed in 2023 as per its definition. Drug Development and Registration IF is decreased by a factor of 0.01 and approximate percentage change is -1.33% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2022 of Drug Development and Registration is 0.74. If the same downward trend persists, Impact IF may fall in 2023 as well.
Year | Impact IF |
---|---|
2023/2024 | Coming Soon |
2022 | 0.74 |
2021 | 0.75 |
2020 | 0.29 |
2019 | 0.00 |
Drug Development and Registration has an h-index of 5. It means 5 articles of this journal have more than 5 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Drug Development and Registration is 26585049, 23052066. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Drug Development and Registration is 19643. According to SCImago Journal Rank (SJR), this journal is ranked 0.191. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
Year | SJR |
---|---|
2023/2024 | Coming Soon |
2022 | 0.191 |
2021 | 0.156 |
2020 | |
2019 |
Year | Ranking |
---|---|
2023/2024 | Coming Soon |
2022 | 19643 |
2021 | 20792 |
2020 | 33154 |
2019 | 30753 |
Drug Development and Registration is published by Center of Pharmaceutical Analytics. It's publishing house is located in Russian Federation. Coverage history of this journal is as following: 2020-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Drug Development and Registration is Drug Dev. Regist.. This abbreviation ('Drug Dev. Regist.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Pharmaceutical Science (Q3); Drug Discovery (Q4), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Drug Development and Registration latest impact IF is 0.74. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 0.75 (2021) and 0.00 (2019), respectively, in the last 4 years. Moreover, its average IS is 0.45 in the previous 4 years.
The Drug Development and Registration has an SJR (SCImago Journal Rank) of 0.191, according to the latest data. It is computed in the year 2023. In the past 4 years, this journal has recorded a range of SJR, with the highest being 0.191 in 2022 and the lowest being in 2020. Furthermore, the average SJR of the Drug Development and Registration over the previous 4-year period stands at 0.45.
The latest h-index of the Drug Development and Registration is 5.
The Drug Development and Registration is published by the Center of Pharmaceutical Analytics, with its country of publication being the Russian Federation.
The Drug Development and Registration is currently ranked 19643 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 4 years, this journal has experienced varying rankings, reaching its highest position of 19643 in 2022 and its lowest position of 33154 in 2020.
The standard ISO4 abbreviation for the Drug Development and Registration is Drug Dev. Regist..
Drug Development and Registration is classified as a journal that the Center of Pharmaceutical Analytics publishes.
The Drug Development and Registration encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Drug Development and Registration is assigned the following International Standard Serial Numbers (ISSN): 26585049, 23052066.
The best quartile for the Drug Development and Registration is Q3 (2022).
The Drug Development and Registration coverage history can be summarized as follows: 2020-2022.
Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
---|---|---|---|---|---|
Mathematical Modelling and Analysis | journal | 11315 | Vilnius Gediminas Technical University | 27 | 1.75 |
Howard Journal of Communications | journal | 9564 | Taylor and Francis Ltd. | 36 | 1.66 |
Exploration Geophysics | journal | 16383 | Taylor and Francis Ltd. | 48 | 1.17 |
SPE International Formation Damage Control Symposium Proceedings | conference and proceedings | 21934 | 16 | 0.00 | |
Nigerian journal of medicine : journal of the National Association of Resident Doctors of Nigeria | journal | 25905 | National Association of Resident Doctors of Nigeria | 25 | 0.00 |
Brazilian Symposium of Computer Graphic and Image Processing | conference and proceedings | 16004 | 32 | 0.00 | |
Cardiovascular Journal of Africa | journal | 16569 | Clinics Cardive Publishing (PTY)Ltd | 39 | 0.66 |
Physica Status Solidi - Rapid Research Letters | journal | 6699 | Wiley-VCH Verlag | 76 | 2.77 |
Journal of Evolutionary Psychology | journal | 28897 | Akademiai Kiado | 0 | 0.00 |
American Journal of Immunology (discontinued) | journal | 19764 | Science Publications | 12 | 1.56 |
Year | Impact Score (IS) |
---|---|
2023/2024 | Coming Soon |
2022 | 0.74 |
2021 | 0.75 |
2020 | 0.29 |
2019 | 0.00 |